• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 3D 成像流式细胞术和人工智能进行多模态 NASH 预后,以对肝细胞进行特征分析。

Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells.

机构信息

Department of Electrical and Computer Engineering, University of California San Diego, La Jolla, CA, 92093, USA.

Viscient Biosciences Inc, San Diego, CA, 92121, USA.

出版信息

Sci Rep. 2022 Jul 1;12(1):11180. doi: 10.1038/s41598-022-15364-7.

DOI:10.1038/s41598-022-15364-7
PMID:35778474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9249889/
Abstract

To improve the understanding of the complex biological process underlying the development of non-alcoholic steatohepatitis (NASH), 3D imaging flow cytometry (3D-IFC) with transmission and side-scattered images were used to characterize hepatic stellate cell (HSC) and liver endothelial cell (LEC) morphology at single-cell resolution. In this study, HSC and LEC were obtained from biopsy-proven NASH subjects with early-stage NASH (F2-F3) and healthy controls. Here, we applied single-cell imaging and 3D digital reconstructions of healthy and diseased cells to analyze a spatially resolved set of morphometric cellular and texture parameters that showed regression with disease progression. By developing a customized autoencoder convolutional neural network (CNN) based on label-free cell transmission and side scattering images obtained from a 3D imaging flow cytometer, we demonstrated key regulated cell types involved in the development of NASH and cell classification performance superior to conventional machine learning methods.

摘要

为了深入理解非酒精性脂肪性肝炎(NASH)发展背后的复杂生物学过程,本研究采用具备透射和侧向散射成像功能的三维成像流式细胞术(3D-IFC),以单细胞分辨率对肝星状细胞(HSC)和肝内皮细胞(LEC)的形态进行了特征描述。本研究中,HSC 和 LEC 取自活检证实的早期 NASH(F2-F3)和健康对照者。我们通过单细胞成像和对健康和患病细胞的 3D 数字重建,分析了一组具有空间分辨率的形态计量学细胞和纹理参数,这些参数随疾病进展而呈现出退行性变化。我们基于从 3D 成像流式细胞仪获得的无标记细胞透射和侧向散射图像,开发了定制的自动编码器卷积神经网络(CNN),从而证明了参与 NASH 发展的关键调节细胞类型,并实现了优于传统机器学习方法的细胞分类性能。

相似文献

1
Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells.使用 3D 成像流式细胞术和人工智能进行多模态 NASH 预后,以对肝细胞进行特征分析。
Sci Rep. 2022 Jul 1;12(1):11180. doi: 10.1038/s41598-022-15364-7.
2
Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH.借助人工智能分析的数字病理学能更深入地洞察非酒精性脂肪性肝炎(NASH)中治疗引起的纤维化消退情况。
J Hepatol. 2022 Nov;77(5):1399-1409. doi: 10.1016/j.jhep.2022.06.018. Epub 2022 Jun 30.
3
Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.富含半胱氨酸的酸性分泌蛋白相关模块化钙结合蛋白2在星状细胞中的表达与人类非酒精性脂肪性肝病的严重程度相关。
JHEP Rep. 2022 Oct 28;5(2):100615. doi: 10.1016/j.jhepr.2022.100615. eCollection 2023 Feb.
4
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.气球样变肝细胞特征识别的复杂性:为非酒精性脂肪性肝病基于人工智能的成像定义一个训练图谱。
J Hepatol. 2022 May;76(5):1030-1041. doi: 10.1016/j.jhep.2022.01.011. Epub 2022 Jan 25.
5
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.纤维化分期而非 NASH 可预测经活检证实的非酒精性脂肪性肝病患者的死亡率和严重肝脏疾病的发生时间。
J Hepatol. 2017 Dec;67(6):1265-1273. doi: 10.1016/j.jhep.2017.07.027. Epub 2017 Aug 10.
6
Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.CC 趋化因子受体 9 在小鼠和人类非酒精性脂肪性肝炎进展中的作用。
J Hepatol. 2021 Mar;74(3):511-521. doi: 10.1016/j.jhep.2020.09.033. Epub 2020 Oct 8.
7
Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis.人工智能在非酒精性脂肪性肝病和纤维化预测中的应用。
J Gastroenterol Hepatol. 2021 Mar;36(3):543-550. doi: 10.1111/jgh.15385.
8
Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis.基于 CT 纹理分析的非酒精性脂肪性肝炎影像学预测。
Eur Radiol. 2018 Jul;28(7):3050-3058. doi: 10.1007/s00330-017-5270-5. Epub 2018 Feb 5.
9
Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.肝星状细胞中胰岛素-PI3K/Akt-p70S6K信号通路的激活促进非酒精性脂肪性肝炎中的肝纤维化。
Dig Dis Sci. 2017 Apr;62(4):968-978. doi: 10.1007/s10620-017-4470-9. Epub 2017 Feb 13.
10
Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH).新型口服 SPT 抑制剂 CH5169356 抑制非酒精性脂肪性肝炎(NASH)小鼠模型中肝星状细胞的激活并改善肝纤维化。
Pharmacol Res Perspect. 2023 Jun;11(3):e01094. doi: 10.1002/prp2.1094.

引用本文的文献

1
Highly Efficient Calibration-Free Color Compensation Algorithm for Imaging Flow Cytometry.用于成像流式细胞术的高效免校准颜色补偿算法
Cytometry A. 2025 May;107(5):309-320. doi: 10.1002/cyto.a.24931. Epub 2025 Apr 9.
2
Predicting cell properties with AI from 3D imaging flow cytometer data.利用人工智能从三维成像流式细胞仪数据预测细胞特性。
Sci Rep. 2025 Feb 17;15(1):5715. doi: 10.1038/s41598-024-80722-6.
3
Recent Technologies on 2D and 3D Imaging Flow Cytometry.二维和三维成像流式细胞术的最新技术

本文引用的文献

1
A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates.一种用于临床药物候选物疗效测试的非酒精性脂肪性肝炎的三维原代人源细胞体外模型。
Sci Rep. 2021 Nov 23;11(1):22765. doi: 10.1038/s41598-021-01951-7.
2
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis.对肝的单细胞和批量转录组学研究揭示了具有纤维化的 NASH 的潜在靶点。
Sci Rep. 2021 Sep 29;11(1):19396. doi: 10.1038/s41598-021-98806-y.
3
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease.
Cells. 2024 Dec 16;13(24):2073. doi: 10.3390/cells13242073.
4
Imaging Flow Cytometry: Development, Present Applications, and Future Challenges.成像流式细胞术:发展、当前应用及未来挑战
Methods Protoc. 2024 Mar 23;7(2):28. doi: 10.3390/mps7020028.
5
Interpretable unsupervised learning enables accurate clustering with high-throughput imaging flow cytometry.可解释的无监督学习可实现高通量成像流式细胞术的精确聚类。
Sci Rep. 2023 Nov 23;13(1):20533. doi: 10.1038/s41598-023-46782-w.
循环 miRNA 是一种用于非酒精性脂肪性肝病中非酒精性肝炎的有用的诊断生物标志物。
Sci Rep. 2021 Jul 19;11(1):14639. doi: 10.1038/s41598-021-94115-6.
4
Non-Alcoholic Fatty Liver Disease: Implementing Complete Automated Diagnosis and Staging. A Systematic Review.非酒精性脂肪性肝病:实现完全自动化诊断与分期。一项系统评价。
Diagnostics (Basel). 2021 Jun 12;11(6):1078. doi: 10.3390/diagnostics11061078.
5
Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.非酒精性脂肪性肝病中的肝纤维化:从肝活检到诊断和治疗中的非侵入性生物标志物
Front Med (Lausanne). 2021 Apr 14;8:615978. doi: 10.3389/fmed.2021.615978. eCollection 2021.
6
Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease.靶向肝窦内皮细胞:一种控制非酒精性脂肪性肝病炎症的有吸引力的治疗策略。
Front Pharmacol. 2021 Apr 15;12:655557. doi: 10.3389/fphar.2021.655557. eCollection 2021.
7
Evolution of the liver biopsy and its future.肝活检的发展历程及其未来。
Transl Gastroenterol Hepatol. 2021 Apr 5;6:20. doi: 10.21037/tgh.2020.04.01. eCollection 2021.
8
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.开发一种新型机器学习模型以预测非酒精性脂肪性肝炎的存在。
J Am Med Inform Assoc. 2021 Jun 12;28(6):1235-1241. doi: 10.1093/jamia/ocab003.
9
A 3D Human Liver Model of Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎的3D人体肝脏模型
J Clin Transl Hepatol. 2020 Dec 28;8(4):359-370. doi: 10.14218/JCTH.2020.00015. Epub 2020 Dec 15.
10
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments.非酒精性脂肪性肝炎:其发病机制、模型及医学治疗的综述
Front Pharmacol. 2020 Dec 3;11:603926. doi: 10.3389/fphar.2020.603926. eCollection 2020.